Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2022
Jan. 31, 2021
Current assets:    
Cash and cash equivalents $ 17,528 $ 5,856
Marketable securities   252
Accounts receivable, net of allowance for doubtful accounts of $500 and $934 at January 31, 2022 and January 31, 2021, respectively 8,819 6,050
Unbilled receivables 9,160 9,359
Prepaid expenses and other current assets 2,310 4,372
Total current assets 37,817 25,889
Property and equipment, net 902 605
Operating lease right-of-use assets 2,031 4,968
Intangible assets, net   1,272
Goodwill 9,882 10,577
Unbilled receivables 3,952 6,340
Other assets 612 757
Total assets 55,196 50,408
Current liabilities:    
Accounts payable 2,960 1,825
Accrued expenses 4,217 4,277
Deferred revenue 3,947 4,737
Promissory note   1,340
Total current liabilities 11,124 12,179
Deferred revenue 77 657
Operating lease liabilities 1,361 4,070
Taxes payable 110 763
Promissory note   1,073
Other liabilities   125
Total liabilities 12,672 18,867
Commitments and contingencies (Note 7)
Stockholders' equity:    
Common stock, $0.01 par value per share; 100,000,000 shares authorized; 49,347,604 shares issued and 49,175,684 shares outstanding at January 31, 2022; 37,811,224 shares issued and 37,639,304 shares outstanding at January 31, 2021 493 378
Additional paid-in capital 265,644 246,446
Treasury stock, at cost; 171,920 shares at January 31, 2022 and January 31, 2021 (227) (227)
Accumulated other comprehensive loss (973) (73)
Accumulated deficit (222,413) (214,983)
Total stockholders' equity 42,524 31,541
Total liabilities and stockholders' equity $ 55,196 $ 50,408